Johnson & Johnson announces human trials for a coronavirus vaccine

Via Shutterstock

Massive American corporation Johnson & Johnson announced this week that they would begin human trials of a vaccine for the novel coronavirus this fall. While they’re not the first to do it, they’re certainly the biggest.

And, they’ve secured $450M USD in funding from the US Government to achieve their goal. According to a press release from the company, the goal of this is to properly fund vaccine research, development, and clinical testing. And while $450M is a lot, the total amount pledged is currently sitting at $1B. Guess one of the world’s most valuable companies doesn’t mess around.

Now, here’s the interesting part. Basically, the announcement means that Johnson & Johnson is risking a significant amount of money to more or less bet on the vaccine. It’s an educated bet, no doubt, but desperate times call for desperate measures.

If successful, the proposed vaccine could be ready as early as 2021. Fingers crossed, and you can read the press release in full right here.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.